Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Novonesis AS Director's Dealing 2016

Apr 26, 2016

3377_rns_2016-04-26_f1957005-be81-4bfd-a71a-50669605b6fb.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

img-0.jpeg

Trading by management and of close relations to management

April 26, 2016

Company announcement No. 22

In accordance with Section 28a of the Danish Securities Trading Act, Novozymes reports the following transactions under ISIN DK0060336014, Novozymes B shares under the symbol NZYMB.

Name Tina Sejersgård Fanø
Relation/category of close relation EVP, Agriculture & Bioenergy
Trading date 25.04.2016
Market Nasdaq OMX Copenhagen A/S
Character of transaction Purchase of shares from exercise of stock options
Volume of transaction buy(+)/ sell (-) +12,385
Value of transaction (DKK) 1,152,137 DKK

Contact information

[email protected]

Martin Riise

+45 3077 0738

[email protected]

Nicolai Agerskov Kobborg

[email protected]

Klaus Sindahl

+45 5363 0134

[email protected]

Name Tina Sejersgård Fanø
Relation/category of close relation EVP, Agriculture & Bioenergy
Trading date 25.04.2016
Market Nasdaq OMX Copenhagen A/S
Character of transaction Sale of shares from exercise of stock options.
Volume of transaction buy(+)/ sell (-) -12,385
Value of transaction (DKK) 3,904,990 DKK

About Novozymes

Novozymes is the world leader in biological solutions. Together with customers, partners and the global community, we improve industrial performance while preserving the planet's resources and helping build better lives. As the world's largest provider of enzyme and microbial technologies, our bioinnovation enables higher agricultural yields, low-temperature washing, energy-efficient production, renewable fuel and many other benefits that we rely on today and in the future. We call it Rethink Tomorrow. www.novozymes.com

Novozymes A/S CVR number: 10 00 71 27

Rethink Tomorrow

novozymes